Form 4: CONMED Corp Director Lande Exercises Stock Options and Reports Beneficial Ownership

Director Jerome J. Lande reports the exercise of stock options and adjustments to beneficial ownership of CONMED Corp shares.

Summary

• On May 31, 2024, Jerome J. Lande, a director of CONMED Corp, reported transactions involving the company's stock.
• Lande exercised stock options, acquiring 302 shares of common stock at a price of $0.
• Following the transaction, Lande directly owns 3,856 shares of CONMED Corp common stock.
• Lande may be deemed the beneficial owner of 1,630,800 shares held by Coppersmith Capital Management, LLC, where he is a Managing Member, but disclaims beneficial ownership except to the extent of his pecuniary interest.
• He also disposed of 302 Restricted Stock Units (RSUs) which converted into common stock.
• A power of attorney was executed on October 3, 2023, granting authority to certain individuals to act on Lande's behalf for Section 16 and Rule 144 filings.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors monitor these filings for insights into management's view of the company's prospects.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves a small number of shares relative to the company's total outstanding shares.

Key Dates